Haley Ramsey, PhD received her BSc from the University of Tennessee and her PhD from the Medical University of Vienna, where she was credited with creating the first murine model of alloreactive mismatch T memory cells for use in bone marrow, heart, and skin transplantation studies.
Prior to moving to Vanderbilt in 2015, she was a postdoctoral fellow at Harvard Medical School, where she studied myelodysplastic syndrome and hemostasis. Her expertise in the modeling of malignant hematologic disorders is accompanied by her interests in determining the underlying mechanisms of novel cancer therapies. She is currently designs pre-clinical studies for novel therapies in Acute Myeloid Leukemia, and effects of therapy on tumor metabolism.
Dr. Ramsey is the recipient of awards from the American Society of Hematology, Harvard Medical School, Children’s Hospital in Boston, Massachusetts General Hospital, and Roche.